Vax d Therapy Results

Many people's lives have been altered negatively due to their back pain problems. These lower back pains or upper back pains can be attributed to stress or day-to- day problems, or they could be attributed to something more serious. If your back problems are hindering your ability to live the life you want, it is a good idea to look into chiropractic, physical therapy, and spinal decompression treatment protocols for low back pain such as VAX-D. This new development has demonstrated its ability to successfully treat back pain for people all over the United States. Recently, data was collected from twenty two medical centers in the USA for patients who received VAX-D therapy for low back pain. Patients who received at least 10 treatments and had a diagnosis of herniated disc, degenerated disc, or facet syndrome, which was confirmed by imaging studies, were included in the study. The average number of treatments was 17 for facet syndrome, 19 for degenerative disc disease, and 20 for other diagnoses. The data contained the patients' assessment of their own pain, mobility, and ability to walk and sit. The pain scale ran from no pain to severe pain. The mobility limitation scale was: No limitation, slightly limited, very limited, and completely immobile. The activity limitation scale was: walks frequently, walks occasionally, chair fast, and bedfast. The treatment schedule, including the use of other modalities, the duration and frequency of VAX-D therapy, and medication was also recorded, as well as the patient's history. The symptoms were recorded at the beginning, mid-point, and end of the treatment schedule. The patients' satisfaction with the treatment was quantified as: not satisfied, slightly satisfied, very satisfied, and completely satisfied.

The data were divided into five groups: The first group, which contained 34 cases, included all patients with extruded herniated discs, whether or not additional lesser problems were present. The second group contained 195 cases of multiple herniated discs, without extrusion, with or without degenerative disc disease. The third group consisted of 382 patients with a single herniated disc, regardless of degenerative disease. The fourth group contained 147 cases of degenerative disc disease, without herniation. The fifth group contained 19 cases with facet syndrome. Five cases of facet syndrome which had a pain reduction to 0 or 1 before 10 treatments, and one that had a reduction to 2, received less than 10 total treatments, so they were not included in the data base.

If treatment success is defined as a reduction in pain to 0 or 1 on a 0 to 5 scale, the treatment was successful in 71% of the 778 cases. The success rate varied from 53% for the patients with extruded herniated discs, to 73% for patients with a single herniated disc. It was 72% for people with multiple herniated discs and 68% for facet syndrome. On a pain scale of 0 to 5, the people with extruded herniated discs had an average pain of 4.16 at the beginning of treatment and an average of 1.82 after treatment, a reduction of 56%. The cases of multiple herniated discs went from 4.13 to 1.18, a reduction of 71%. The patients with a single herniation had a reduction from 4.16 to 1.09, or 71%. The degenerative disc cases reduced from 3.93 to 1.17, a 70% reduction. The patients with facet syndrome had a reduction of 4.00 to 1.13, a 72% reduction in pain. Overall, 71% of the patients experienced a reduction in pain to 0 or 1. The reduction in the average pain score was also 71%. One percent of the patients reported increased pain, 7% had no change, 92% improved by 1 unit or more, 87% improved by 2 units or more, and 70% improved by 3 units or more.